Member Login
  1. Stocks
    2. /
  2. Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)
    3. /

NASDAQ:RXRX (Recursion Pharmaceuticals, Inc.)

About RXRX

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

  • Should you invest £1,000 in Recursion Pharmaceuticals, Inc. right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    Mark and his analyst team just revealed what they believe are the 6 best stocks for investors to buy right now... and Recursion Pharmaceuticals, Inc. wasn’t on the list. Right now, they think there are 6 stocks that are better buys!

    See the 6 stocks

    • Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) Latest News

    Investing Articles

    Could this Nvidia-backed growth stock be a millionaire-maker at $10?

    | Ben McPoland

    This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a single day!

    Read more »

    Investing Articles

    Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

    | Ben McPoland

    Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

    Read more »

    Businesswoman analyses profitability of working company with digital virtual screen
    Investing Articles

    2 growth stocks I’d buy for the artificial intelligence (AI) revolution in 2024

    | Ben McPoland

    Ben McPoland takes a look at two intriguing and yet under-the-radar growth stocks that could deliver huge long-term returns.

    Read more »